Pulm Flashcards

1
Q

Pathophys of asthma

A

Airway inflammation via mast cells, eosinophils, epithelial, cells, macrophages, and activated T lymphocytes
Airflow obstruction via acute bronchoconstriction, airway edema, chronic mucous plug formation, and airway remodeling
Hyperinflation to compensate for the airflow obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Factors that can contribute to asthma or airway hyperreactivity

A
Environmental allergens
Viral respiratory tract infections
Exercise, hyperventilation
Gastroesophageal reflux disease
Chronic sinusitis or rhinitis
ASA or NSAID hypersensitivity, sulfite sensitivity
Use of BBs
Obesity
Environmental pollutants, tobacco smoke
Occupational exposure
Irritants
Various high and low molecular weight compounds
Emotional factors or stress
Perinatal factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

FHx of asthma

A
May be pertinent for:
Asthma
Allergy
Sinusitis
Rhinitis
Eczema
Nasal polyps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Exacerbation history of asthma

A

Usual prodromal signs or sx
Rapidity of onset
Associated illnesses
Number in the last year
Need for ED visits, hospitalizations, ICU admissions, intubations
Missed days from work or school or activity limitation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

General manifestations of asthma

A

Wheezing is one of the most common sx
-However not necessary for the dx
Cough may be the only symptom of asthma
Other non-specific sx in infants or young children:
-Hx of recurrent bronchitis, bronchiolitis, or PNA
-Persistent cough with colds
-Recurrent croup or chest rattling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mild episode PE- asthma

A
Pts may be breathless after physical activity such as walking
Able to lie flat
RR is increased
Accessory muscles are not used
HR <100
Pulsus paradoxus not present
Moderate wheezing, often end-expiratory
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Moderately severe episode PE- asthma

A
RR is increased
Accessory muscles are used
In children, supraclavicular and intercostal retractions, nasal flaring, abdominal breathing
HR 100-120 
Loud expiratory wheezing
Pulsus paradoxus may be present
SpO2 91-95%
Breathless while talking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Severe episode PE- asthma

A
Pts are breathless at rest
Not interested in eating
Sit upright
Talk in words rather than sentences
Usually agitated
RR >30 
Accessory muscles
Suprasternal retractions
HR >120 bpm
Loud biphasic wheezing
Pulsus paradoxus if often present
SpO2 <91%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Imminent respiratory arrest PE- asthma

A

Children- Drowsy and confused
Status asthmaticus- paradoxical thoracoabdominal movement
Wheezing may be absent, and severe hypoxemia may manifest as bradycardia
Pulsus paradoxus may be absent
As it becomes more severe, profuse diaphoresis
Pts may struggle for air, act confused and agitated and pull off their oxygen
Almost no breath sounds may be heard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nonpulmonary manifestations of asthma

A
Signs of atopy or allergic rhinitis:
Conjunctival congestion and inflammation
Ocular shiners
Transverse crease on the nose
Pale violaceous nasal mucosa
Turbinates may be erythematous or boggy
Polyps may be present
Skin:
Atopic dermatitis
Eczema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nocturnal sx of asthma

A

Bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Workup of asthma

A
Labs are not routinely indicated for the dx of asthma, but they may be used to exclude other diagnoses
ABG and SpO2 are valuable for assessing severity of exacerbations and following response to tx
CXR
EKG for severe sx
Allergy skin testing
PFTs
Bronchoprovocation
Peak flow monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tx of asthma

A

Avoidance of allergens
Avoid tobacco smoke
Consider immunotherapy if a relationship is clear between sx and exposure to an unavoidable allergen to which the pt is sensitive, sx occur all year or during a major portion of the year, or sx are difficult to control with pharmacologic management
Stepwise therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pathophys of acute bronchitis

A

The cells of the bronchial lining tissue are irritated and the mucous membrane becomes hyperemic and edematous, diminishing bronchial mucociliary function
Consequently, the air passages become clogged by debris and irritation increases
In response, copious secretion of mucus develops

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Etiology of acute bronchitis

A

MC viruses include influenza A and B, parainfluenza, RSV, and coronavirus
Usually called by infections, such as Mycoplasma, C. pneumoniae, S. pneumoniae, M. catarrhalis, and H. influenza and by viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hx of acute bronchitis

A
Cough generally lasts from 10-20 days
Sputum production may be clear, yellow, green, or even blood-tinged
Fever relatively unusual
Sore throat
Runny or stuffy nose
HA
Muscle aches
Extreme fatigue
17
Q

PE of acute bronchitis

A

Can vary from nl-to-pharyngeal erythema, localized LAD, and rhinorrhea to coarse rhonchi and wheezes that change in location and intensity after a deep and productive cough

18
Q

Workup of acute bronchitis

A
CBC with diff
Procalcitonin levles
Sputum cytology if cough is persistent
CXR in those pts whose PE findings suggest pneumonia
Culture
19
Q

Tx of acute bronchitis

A

Central cough suppressants, such as codeine and dextromethorphan
NSAIDs
Guaifenesin
Abx recommended in pts >65 years with acute cough if they have had a hospitalization in the past year, have DM or congestive heart failure, or on steroids

20
Q

Pathophys of COPD- chronic bronchitis

A

Mucous gland hyperplasia
Airway structural changes include atrophy, focal squamous metaplasia, ciliary abnormalities, variable amounts of airway smooth muscle hyperplasia, inflammation, and bronchial wall thickening

21
Q

Pahophys of COPD- emphysema

A

Permanent enlargement of airspaces distal to the terminal bronchioles, leading to a dramatic decline in the alveolar surface area available for gas exchange

22
Q

Etiology of COPD

A
Cigarette smoking
Environmental factors
Airway hyperresponsiveness
Alpha1-antitrypsin deficiency
IVDU
Immunodeficiency syndromes
Vasculitis syndrome
Connective tissue d/os
Salla disease
23
Q

Hx of COPD

A
Cough
Worsening dyspnea
Progressive exercise intolerance
Sputum production
Alteration in mental status
Wheezing
Breathlessness
Systemic manifestations:
Decreased fat-free mass
Impaired systemic muscle function
Osteoporosis
Anemia
Depression
Pulmonary HTN
Cor pulmonale
Left-sided heart failure
24
Q

PE of COPD

A
Hyperinflation
Wheezing
Diffusely decreased breath sounds
Hyperresonance on percussion
Prolonged expiration
Coarse crackles beginning with inspiration
25
Q

PE of COPD specific to chronic bronchitis

A

Pts may be obese
Frequent cough and expectoration are typical
Use of accessory muscles of respiration is common
Coarse rhonchi and wheezing may be heard on auscultation
Pts may have signs of right heart failure, such as edema and cyanosis

26
Q

PE of COPD specific to emphysema

A

Pts may be very thin with a barrel chest
Pts typically have little or no cough or expectoration
Breathing may be assisted by pursed lips and use of accessory respiratory muscles; pts may adopt the tripod sitting position
The chest may be hyperresonant, and wheezing may be heard
Heart sounds are very distant
Overall appearance is more like classic COPD exacerbation

27
Q

Stagin of COPD

A

With the caveat that there is also the BODE index
Stage I: FEV1 80% or greater of predicted
Stage II: FEV1 50-79% of predicted
Stage III: FEV1 30-49% of predicted
Stage IV: FEV1 <30% of predicted

28
Q

Workup of COPD

A
Formal dx is made with spirometry
ABG for exacerbation
Serum chemistries
Alpha1-antitrypsin in all pts <40 yos, in those with FHx of emphysema at an early age, or pts with emphysematous changes with no smoking hx
Sputum eval with exacerbation
CXR
CT
PFTs
Six-minute walking distance
29
Q

Tx of COPD

A

Smoking cessation
Inhaled corticosteroids as an adjunct to a LABA if necessary
Use antibiotics for exacerbation